Methodology for the synthesis of pyridines and pyridones: Development and applications

Heterocycles

Volumn 74, Issue C, 2007, Pages 101-124

  Ciufolini, Marco A ^a   Chan, Bryan K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40749083200     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Gill N.S., James K.B., Lions F., and Potts K.T. J. Am. Chem. Soc. 74 (1952) 4923
2. Stobbe H., and Striegler C. J. Prakt. Chem. 86 (1912) 241
3. Knoevenagel E., and Weissgerber R. Ber. 26 (1893) 436
4. Haffner Cf.K. Tetrahedon Lett 35 (1994) 1349 (31% yield)
5. Paul R., and Tschelitscheff S. Bull. Soc. Chim. Fr. (1954) 1139
6. Heathcock C.H., Kleinmn E.F., and Binkley E.S. J. Am. Chem. Soc. 104 (1982) 1054 and refs. cited therein.
7. Kametani's pioneering studies on streptonigrin are especially informative:. Kametani T., Kozuka A., and Tanaka S. Yakugaku Zasshi 90 (1970) 1574
8. Kametani T., Tanaka S., and Kozuka A. Yakugaku Zasshi 91 (1971) 1068
9. The term "cycloaddition" as used in this paper is only meant to describe the outcome of the reaction of a conjugated carbonyl compound with a vinyl ether, and it should not be construed as implying any particular mechanism for the process.
10. Longley R.I., Emerson W.S., and Blardinelli A.J. Org. Synth. Coll. IV (1963) 311 See especially Note 6 therein.
11. Danishefsky S., and Bednarski M. Tetrahedron Lett. 25 (1984) 721
12. The major frontier orbital interaction involved in this process occurs between the HOMO of the vinyl ether and the LUMO of the enone. Conjugation of the enecarbonyl system with an aryl group lowers the LUMO energy (EHMO calculations), diminishing the HOMO-LUMO gap and accelerating the reaction.
13. Interestingy, lanthanide complexes are poor catalysts for the analogous reaction of simple aliphatic enones. For an exceptional case see:. Chapleur Y., and Euvrard M.-N. J. Chem. Soc., Chem. Commun. (1987) 884
14. Ethanol was initially employed as the solvent in this step (see ref. 10), but MeCN was later found to be superior. In many cases, the use of MeCN is essential to achieve an efficient conversion.
15. Ciufolini M.A., and Byrne N.E. J. Chem. Soc., Chem. Commun (1988) 1230
16. Byrne N.E. Dissertation (1991), Rice University
17. Ciufolini M.A. In: Pearson W.H. (Ed). Advances in Heterocyclic Natural Product Synthesis (1996), JAI Press, Greenwich, CT 1
18. For additional examples of this useful reaction see:. Cordaro J.G., McCusker J.K., and Bergman R.G. Chem. Commun. (2002)
19. Beschke H. Aldrichimica Acta 11 (1978) 13
20. Hoff S., Brandsma L., and Arens J.F. Rec. Tray. Chim. Pays-Bas 87 (1968) 916
21. Hosomi A., Hashimoto H., and Sakurai H. J. Org. Chem. 43 (1978) 2551
22. Ciufolini M.A., and Roschangar F. Tetrahedron 53 (1997) 11049
23. That such failures are due primarily to steric or to electronic problems is borne out of computational investigations (EHMO and MM+ methods).
24. Leading reviews:. Li Z., Jin Z., and Huang R. Synthesis (2001) 2365
25. Gellert E. In: Pelletier S.W. (Ed). 'Alkaloids: Chemical and Biological Perspectives,' Vol 5 (1987), John Wiley & Sons, New York 55
26. Suffness M., and Cordell G.A. In: Brossi A. (Ed). 'The Alkaloids,' Vol. 25 (1985), Academic Press, Inc, Orlando 156
27. Bick R.C., and Sinchai W. In: Rodrigo R.G.A. (Ed). 'The Alkaloids,' Vol 19 (1981), Academic Press, New York 193
28. Govindachari T.R., and Viswanathan N. Heterocycles 11 (1978) 587
29. Recent work:. Wei L., Shi Q., Bastow K.F., Brossi A., Morris-Natschke S.L., Nakagawa-Goto K., Wu T.-S., Pan S.L., Teng C.-M., and Lee K.-S. J. Med. Chem. 50 (2007) 3674
30. Yang C.-W., Chuang T.-H., Wu P.-L., Huang W.-H., and Lee S.-J. Biochem. Biophys. Res. Commun. 354 (2007) 942
31. Wei L., Brossi A., Kendall R., Bastow K.F., Morris-Natschke S.L., Shi Q., and Lee K.-H. Bioorg. Med. Chem. 14 (2006) 6560
32. Gao W., Lam W., Zhong S., Kaczmarek C., Baker D.C., and Cheng Y.-C. Cancer Res 64 (2004) 678 as well as ref. 16.
33. Yang C.-W., Chen W.-L., Wu P.-L., Tseng H.-Y., and Lee S.-J. Mol. Pharmacol. 69 (2006) 749 and refs. cited therein.
34. This compound was not a known natural product at that time, but it was subsequently isolated from Cynanchum vincetoxicum:. Strk D., Lykkeberg A.K., Christensen J., Budnik B.A., Abe F., and Jaroszewski J.W. J. Nat. Prod. 65 (2002) 1299
35. Ciufolini M.A., and Roschangar F. J. Am. Chem. Soc. 118 (1996) 12082
36. Balitz D.M., Bush J.A., Bradner W.T., Doyle T.W., O'Herron F.A., and Nettleton D.E. J. Antibiot. 35 (1982) 259
37. Gould S.J., and Chang C.C. J. Am. Chem. Soc. 102 (1980) 1702
38. Gould S.J., Chang C.C., Darling D.S., Roberts J.D., and Squillacote M. J. Am. Chem. Soc. 102 (1980) 1707
39. Reviews:. Bringmann G., Reichert Y., and Kane V.V. Tetrahedron 60 (2004) 3539
40. Boger D.L. Strategies Tactics Org. Synth. 2 (1989) 1
41. Gould S.J., and Weinreb S.M. prog. Chem. Org. Nat. Prod. 41 (1982) 77
42. For instance: inhibition of NO-dependent activation of soluble guanylyl cyclase:. Severina I.S., Pyatakova V., Postnikov A.B., Preobrazhenskaya M.N., and Khropov Y.V. Eur. J. Pharmacol. 483 (2004) 127
43. inhibition of ras farnesylation:. Liu W.C., Barbacid M., Bulgar M., Clark J.M., Crosswell A.R., Dean L., Doyle T.W., Fernandes P.B., Huang S., Manne V., Pirnik D.M., Wells J.S., and Meyers E. J. Antibiot. 45 (1992) 454
44. inhibition of reverse transcriptase:. Okada H., Mukai H., Inouye Y., and Nakamura S. J. Antibiot. 39 (1986) 306
45. induction of topoisomerase II-dependent DNA cleavage:. Yamashita Y., Kawada S., Fujii N., and Nakano H. Cancer Res. 50 (1990) 5841
46. Recent work:. Fryatt T., Pettersson H.I., Gardipee W.T., Green S.J., Slawin A.M.Z., Beall H.D., and Moody C.J. Bioorg. Med. Chem 12 (2004) 1667
47. McElroy W.T., and DeShong P. Tetrahedron 62 (2006) 6945 and references cited therein.
48. Leading reviews:. Delfourne E., and Bastide J. Med. Res. Rev. 23 (2003) 234
49. Skyler D., and Heathcock C.H. J. Nat. Prod. 65 (2002) 1573
50. Ding Q., Chichak K., and Lown J.W. Curr. Med. Chem. 6 (1999) 1
51. Molinski T.F. Chem Rev. 93 (1993) 1825
52. McRobbie I.M., Meth-Cohn O., and Suschitzky H. J. Chem. Research 17 (1977)
53. Lindley J.M., McRobbie I.M., Meth-Cohn O., and Suschitzsky H. J. Chem. Soc., Perkin Trans. 1 (1977) 2194
54. We presume that the reaction actually proceeds through a 4-electron electrocyclization of the singlet nitrene, followed by a [1,5]-sigmatropic H shift.
55. Controversy persists regarding the precise mechanism of such reactions, especially with regard to the spin state of the nitrene:. Smolinsky G. J. Am. Chem. Soc. 83 (1961) 2489
56. Swenton J.S. Tetrahedron Lett (1968) 3421
57. Swenton J.S., Ikeler I.J., and Williams B.H. J. Am. Chem. Soc. 92 (1970) 3103
58. Smith P.A.S. In: Scriven E.F.V. (Ed). 'Azides and Nitrenes: Reactivity and Utility, (1984), Academic Press, Inc., Orlando, FL Chapter 3.
59. Thermolysis of 69 also proceeded smoothly; however, the ensuing carboline resisted oxidation of the pyridine C-6 methyl group, arguably due to the presence of the electron-donating N-substituent on the pyridine ring:. Wittek P.J., Liao T.K., and Cheng C.C. J. Org. Chem. 44 (1979) 870
60. Boger D.L., Duff S.R., Panek J.S., and Yasuda M. J. Org. Chem. 50 (1985) 5790
61. Ciufolini M.A., and Bishop M.J. J. Chem. Soc., Chem. Commun. (1993) 1463
62. Ciufolini M.A., and Byrne N.E. J. Am. Chem. Soc. 113 (1991) 8016
63. Ciufolini M.A., and Shen Y.-C. Tetrahedron Lett. 36 (1995) 4709
64. Ciufolini M.A., Shen Y.-C., and Bishop M.J. J. Am. Chem. Soc. 117 (1995) 12460
65. Bishop M.J., and Ciufolini M.A. J. Am. Chem. Soc. 114 (1992) 10081
66. Leading references - chemistry:. Wall M.E., and Wani M.C. In: Cordell G.A. (Ed). 'The Alkaloids,' vol 50 (1998), Academic Press, Inc., San Diego, CA, ch. 13.
67. Kawato Y., and Terasawa H. Progr. Med. Chem. 34 (1997) 69
68. Du W. Tetrahedron 59 (2003) 8649
69. Pharmacology:. RandalI-Whitis L.M., and Monk B.J. Exp. Opinion Pharmacother. 8 (2007) 227
70. Li Q.Y., Zu Y.G., Shi R.-Z., and Yao L.P. Curr. Med. Chem. 13 (2006) 2021
71. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., and Sim G.A. J. Am. Chem. Soc. 88 (1966) 3888
72. Hsiang Y.H., Herzberg R., Hecht S., and Liu L.F. J. Biol. Chem. 260 (1985) 14873
73. Philippart P., Harper L., Chaboteaux C., Decaestecker C., Bronckart K., Gordover L., Lesueur-Ginot L., Malonne H., Lavergne O., Bigg D.C.H., da Costa P.M., and Kiss R. R. Clin. Cancer Res. 6 (2000) 1557
74. Stewart C.F. Cancer Chemother. Biol. Resp. Modif 19 (2001) 85
75. Arun B., and Frenkel E.P. Exp. Opin. Pharmacother. 2 (2001) 491
76. Review:. Kreditor M., Fink M., and Hochster H.S. Cancer Chemother. Biol. Resp. Modif 22 (2005) 100
77. For emerging drugs derived from CPT see:. Zunino F., and Pratesi G. Exp. Opin. Invest. Drugs 13 (2004) 269
78. Versace R.W. Exp. Opin. Ther. Patents 13 (2003) 751
79. Discussion:. Meislich H. In: Klingsberg E. (Ed). 'Pyridine and its Derivatives,' Vol. 3 (1962), Interscience, Inc, New York, 509
80. Ruby P.R. In: Klingsberg E. (Ed). 'Pyridine and its Derivatives,' Vol. 1 (1960), Interscience, Inc., New York 99 (see especially p. 286).
81. Otto H.H., and Rinus O. Arch. Pharm. 312 (1979) 548
82. Jones G. In: Katritzky A.R., and Rees C.W. (Eds). 'Comprehensive Heterocyclic Chemistry, Voi. 2A (1984), Pergamon Press, Oxford, UK 395
83. Jain R., Roschangar F., and Ciufolini M.A. Tetrahedron Lett. 19 (1995) 3307
84. Caries L., Narkunan K., Penlou S., Rousset L., Bouchu D., and Ciufolini M.A. J. Org. Chem. 66 (2002) 4304
85. Massiot G., Sousa Oliveira F., and Levy J. Tetrahedron Lett. 23 (1982) 177
86. Additional example of 3-alkylpyridone synthesis by a similar [3+3] construction:. Katritzky A.R., Belyakov S.A., Sorochinsky A.E., Henderson S.A., and Chen J. J. Org. Chem. 62 (1997) 6210
87. The sensitivity of diacylethylenes to the basic conditions of Table 5 mandated such experimental modifications.
88. Ohtsuka T., Shirahama H., and Matsumoto T. Chem. Lett (1981) 1703
89. Stork G., and Schultz A.G. J. Am. Chem. Soc. 16 (1971) 4074
90. Ref. 14 as well as:. Ciufolini M.A., and Roschangar F. Angew. Chem., Int. Ed. Engl 35 (1996) 1692.
91. Ciufolini M.A., and Roschangar F. In: Attanasi O.A., and Spinelli D. (Eds). 'Targets in Heterocyclic Chemistry,' Vol. 3 (2000), Italian Society of Chemistry, Rome
92. Fortunak J.M.D., Mastrocola A.R., Mellinger M., and Wood J.L. Tetrahedron Lett. 35 (1994) 5763
93. E.g.:. Curran D.P., Parniak M.A., and Gabarda A. PCT Int. Appl. (2003) WO 2003103610.
94. For synthetic activity prior to 2002 see refs. 44 and 56. Recent efforts:. Bowman W.R., Cloonan M.O., Fletcher A.J., and Stein T. Org. Biomol. Chem. 3 (2005) 1460
95. Chavan S.P., and Rasapalli S. Tetrahedron Lett. 45 (2004) 3941
96. Raolji G.B., Garqon S., Greene A.E., and Kanazawa A. Angew. Chem. Int. Ed. 42 (2003) 5059
97. Henegar K.E., and Baughman T.A. J. Heterocycl. Chem. 40 (2003) 601
98. Kato I., Higashimoto M., Tamura O., and Ishibashi H. J. Org. Chem. 68 (2003) 7983
99. For similar Pd-mediated reactions of 2-chloroquinolines see:. Ciufolini M.A., Mitchell W., and Roschangar F. Tetrahedron Lett. 37 (1996) 8281
100. Kobayashi Y., Nakano M., Kumar G.B., and Kishihara K. J. Org. Chem. 63 (1998) 7505
101. Hong J., and Boger D.L. J. Am. Chem. Soc. 120 (1998) 1218
102. Shioiri T., Ninomiya K., and Yamada S. J. Am. Chem. Soc. 94 (1972) 6203
103. Ninomiya K., Shioiri T., and Yamada S. Tetrahedron 30 (1974) 2151
104. Weinreb S.M., Basha F.Z., Hibino S., Khatri N.A., Kim D., Pye W.E., and Wu T.-T. J. Am. Chem. Soc. 104 (1982) 536
105. Kim D., and Weinreb S.M. J. Org. Chem. 43 (1978) 125
106. Hibino S., and Weinreb S.M. J. Org. Chem. 42 (1977) 232
107. Chan B.K., and Ciufolini M.A. J. Org. Chem. 72 (2007) 8489